Primary and Secondary Allyltitanium(IV) Reagents in Aldehyde Allylation II: Application to an Enantioselective Preparation of a C1-C7 Fragment of Spiramycin

Abstract

A synthetic approach to the eastern part of spiramycin, an important antibiotic compound, is described. Introduction of the side chain was first envisaged through a Hoppe aldehyde allylation. This reaction was carried out between an optically pure aldehyde 32 and a (±)-γ-alkoxy allyltitanium(IV) species derived from a primary γ-alkoxy allyl (diisopropyl)carbamate. Under kinetic resolution conditions, the anti-Cram compound 35 was obtained in an 80:20 mixture, with the Cram isomer 34, in 81% yield. Employing the optically pure (S)-γ-alkoxy allyl (diisopropyl)carbamate 36, the corresponding (R)-γ-alkoxy allyltitanium (R)-‘Ti’-III was generated under n-BuLi·TMEDA/Ti(Oi-Pr)₄ conditions, that reacted with aldehyde 32 in double stereodifferentiation to deliver the expected Cram compound 40 in 80% yield (95% de). This latter corresponded to the C1-C7 fragment of spiramycin.

spiramycin - synthesis - Hoppe allylation - secondary allyltitanium reagent - double stereodifferentiation

References

<A NAME="RP09204SS-1A">1a</A> Tatsuta K. Amemiya Y. Kanemura Y. Takahashi H. Kinoshita M. Tetrahedron Lett.  1982,  23:  3375 

<A NAME="RP09204SS-1B">1b</A> Nicolaou KC. Seitz SP. Pavia MR. J. Am. Chem. Soc.  1982,  104:  2031 

<A NAME="RP09204SS-1C">1c</A> Masamune S. Lu LD.-L. Jackson WP. Kaiho T. Toyoda T. J. Am. Chem. Soc.  1982,  104:  5523 

<A NAME="RP09204SS-1D">1d</A> Grieco PA. Inanaga J. Lin NH. Yanami T. J. Am. Chem. Soc.  1982,  104:  578 

<A NAME="RP09204SS-1E">1e</A> Tanaka T. Oikawa Y. Hamada T. Yonemitsu O. Chem. Pharm. Bull.  1987,  35:  2219 

<A NAME="RP09204SS-2A">2a</A> Omura S. Sano H. Sunazuka T. J. Antimicrob. Chemother.  1985,  16 Suppl. A:  1 

<A NAME="RP09204SS-2B">2b</A> Omura S. Sano H. Inoue M. Yamashita K. Okachi R. J. Antibiot.  1983,  36:  1336 

<A NAME="RP09204SS-2C">2c</A> Tsuchiya M. Hamada H. Takeuchi T. Umewaza H. Yamamoto K. Tanaka H. Kiyoshima K. Mori S. Okamoto R. J. Antibiot.  1982,  35:  661 

<A NAME="RP09204SS-3A">3a</A> Kirst HA. In Recent Progress in the Chemical Synthesis of Antibiotics   Lucas G. Ohno M. Springer Verlag; Berlin: 1990.  p.39 

<A NAME="RP09204SS-3B">3b</A> In Macrolide Antibiotics   Omura S. Academic Press; New York: 1984. 

<A NAME="RP09204SS-3C">3c</A> Kirst HA. J. Antimicrob. Chemother.  1991,  28:  787 

<A NAME="RP09204SS-4A">4a</A> Berque I. Razon P. Le Ménez P. Aniès C. Pancrazi A. Ardisson J. Synlett  1998,  1129 

<A NAME="RP09204SS-4B">4b</A> Berque I. Razon P. Le Ménez P. Pancrazi A. Ardisson J. Synlett  1998,  1135 

<A NAME="RP09204SS-4C">4c</A> Berque I. Razon P. Le Ménez P. Mahuteau J. Férézou JP. Pancrazi A. Ardisson J. J. Org. Chem.  1999,  64:  373 

<A NAME="RP09204SS-5A">5a</A> Oddon G. Uguen D. Tetrahedron  1997,  38:  4407 

<A NAME="RP09204SS-5B">5b</A> Oddon G. Uguen D. Tetrahedron Lett.  1997,  38:  4411 

<A NAME="RP09204SS-5C">5c</A> Breuilles P. Oddon G. Uguen D. Tetrahedron Lett.  1997,  38:  6607 

<A NAME="RP09204SS-5D">5d</A> Oddon G. Uguen D. De Cain A. Fischer J. Tetrahedron Lett.   1998,  39:  1149 

<A NAME="RP09204SS-5E">5e</A> Oddon G. Uguen D. Tetrahedron Lett.  1998,  39:  1153 

<A NAME="RP09204SS-5F">5f</A> Oddon G. Uguen D. Tetrahedron Lett.  1998,  39:  1157 

<A NAME="RP09204SS-5G">5g</A> For the synthesis of the eastern part of spiramycin, see: Nicolaou KC. Pavia MR. Seitz SP. Tetrahedron Lett.  1979,  25:  2327 

<A NAME="RP09204SS-5H">5h</A> See also: Nicolaou KC. Seitz SP. Pavia MR. J. Am. Chem. Soc.  1981,  103:  1222 

<A NAME="RP09204SS-5I">5i</A> See also: Nicolaou KC. Pavia MR. Seitz SP. J. Am. Chem. Soc.  1981,  103:  1224 

<A NAME="RP09204SS-5J">5j</A> See also: Tatsuta K. Amemiya Y. Maniwa S. Kinoshita M. Tetrahedron Lett.  1980,  21:  2837 

<A NAME="RP09204SS-5K">5k</A> See also: Wuts PMG. Bigelow SS. J. Org. Chem.  1988,  53:  5023 

<A NAME="RP09204SS-6A">6a</A> Hoppe D. Zschage O. Angew. Chem., Int. Ed. Engl.  1989,  28:  69 

<A NAME="RP09204SS-6B">6b</A> Zschage O. Hoppe D. Tetrahedron  1992,  48:  5657 

<A NAME="RP09204SS-6C">6c</A> Zschage O. Hoppe D. Tetrahedron  1992,  48:  8389 

<A NAME="RP09204SS-6D">6d</A> Hoppe D. Hense T. Angew. Chem., Int. Ed. Engl.  1997,  36:  2282 

<A NAME="RP09204SS-6E">6e</A> Hoppe D. Paulsen H. Tetrahedron  1992,  48:  5667 

<A NAME="RP09204SS-6F">6f</A> Férézou J.-P. Julia M. Li Y. Liu LW. Pancrazi A. Bull. Soc. Chim. Fr.  1995,  132:  428 

<A NAME="RP09204SS-6G">6g</A> Smith ND. Kocienski PJ. Street SDA. Synthesis  1996,  652 

<A NAME="RP09204SS-7">7</A> Barton DHR. McCombie SW. J. Chem. Soc., Perkin Trans. 1  1975,  1754 

<A NAME="RP09204SS-8">8</A> Kolb HC. VanNieuwenhze MS. Sharpless KB. Chem. Rev.  1994,  94:  2483 

<A NAME="RP09204SS-9">9</A> Maier ME. Hermann C. Tetrahedron  2000,  56:  557 

<A NAME="RP09204SS-10">10</A>

The structure of 36 was established by comparison of its ¹H and ¹³C NMR spectra with those of compound 46. Analysis of ¹H and ¹³C NMR spectra was supported by 2D experiments.

<A NAME="RP09204SS-11A">11a</A> From racemic secondary crotyl carbamate, see: Zschage O. Schwark J.-A. Hoppe D. Angew. Chem., Int. Ed. Engl.  1990,  29:  296 

<A NAME="RP09204SS-11B">11b</A> See also: Zschage O. Schwark J.-A. Krämer T. Hoppe D. Tetrahedron  1992,  48:  8377 

<A NAME="RP09204SS-11C">11c</A> From optically active secondary crotyl carbamates, see: Hoppe D. Krämer T. Angew. Chem., Int. Ed. Engl.  1986,  25:  160 

<A NAME="RP09204SS-11D">11d</A> See also: Hoppe D. Krämer T. Tetrahedron Lett.  1987,  28:  5149 

<A NAME="RP09204SS-11E">11e</A> See also: Hoppe D. Schwark J.-R. Synthesis  1990,  291 

<A NAME="RP09204SS-11F">11f</A> See also: Zschage O. Hoppe D. Tetrahedron  1992,  48:  8389 

<A NAME="RP09204SS-12">12</A> Razon P. Dhulut S. Bezzenine-Lafollée S. Courtieu J. Pancrazi A. Ardisson J. Synthesis  2004, preceding paper